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Abstract The study of individual cells and cellular net-
works can greatly benefit from the capabilities of micro-
fabricated devices for the stimulation and the recording of
electrical cellular events. In this contribution, we describe
the development of a device, which combines capabilities for
both electrical and pharmacological cell stimulation, and the
subsequent recording of electrical cellular activity. The de-
vice combines the unique advantages of integrated circuitry
(CMOS technology) for signal processing and microfluidics
for drug delivery. Both techniques are ideally suited to study
electrogenic mammalian cells, because feature sizes are of
the same order as the cell diameter, ∼ 50 μm. Despite these
attractive features, we observe a size mismatch between mi-
crofluidic devices, with bulky fluidic connections to the out-
side world, and highly miniaturized CMOS chips. To over-
come this problem, we developed a microfluidic flow cell that
accommodates a small CMOS chip. We simulated the per-
formances of a flow cell based on a 3-D microfluidic system,
and then fabricated the device to experimentally verify the
nutrient delivery and localized drug delivery performance.
The flow-cell has a constant nutrient flow, and six drug inlets
that can individually deliver a drug to the cells. The experi-
mental analysis of the nutrient and drug flow mass transfer
properties in the flowcell are in good agreement with our
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simulations. For an experimental proof-of-principle, we suc-
cessfully delivered, in a spatially resolved manner, a ‘drug’
to a culture of HL-1 cardiac myocytes.
Introduction
Merging the complementary capabilities of electronic chips
and microfluidics will greatly benefit the field of cell bi-
ology. On one hand, electronic chips provide high density
arrays of transducers for electrical recording and stimula-
tion, and, on the other hand, microfluidics offer automated
fluid handling capabilities and tools for the delivery of small,
precise quantities of chemicals. Both techniques have fea-
ture sizes in the micrometer scale, and are ideally suited to
study cell-based systems, such as mammalian cells which
typically have a diameter of 10–50 μm. By combining these
techniques, the response of cellular electrically activity to
chemical and electrical stimulation cues can be thoroughly
investigated.
Microelectrode arrays (MEA) are very useful research
tools for studying electroactive cells, such as neurons and car-
diomyocytes. Since its inception in the early 1970s (Thomas
et al., 1972) most devices were based on electrically con-
ductive lines patterned on glass (typically palladium, gold
(Gross et al., 1995) or indium tin oxide (Gross et al., 1985)),
and are increasingly becoming a standard tool for research
in cell biology (Keefer et al., 2001; Tscherter et al., 2001;
Streit et al., 2001; Jimbo and Robinson, 2000). One cur-
rent limitation of these microelectrode arrays is the diffi-
culty to connect all the electrodes to the off-chip electron-
ics since each electrode requires a dedicated interconnect
to the outside world. The array size is therefore limited by
the available space on the perimeter of the chip that can be
used for interconnects. Moreover, using off-chip electronics
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Fig. 1 Three-dimensional representation of the flow cell. A microma-
chined silicon substrate is etched to form the flowcell. In the central part,
a hole is etched through the wafer to later accommodate the CMOS chip.
At each side of the cavity, channels are formed for the flow of nutrients
across the cavity. The cells are grown in the chamber (i.e., on the surface
of the CMOS chip). A drilled cover plate in Pyrex closes the flowcell.
Nutrients and drug are delivered inside the device through holes and
channels in the PDMS substrate. The coordinate system depicted in the
bottom left part of the scheme defines the directions of the axes used in
the following figures
for signal processing, the electrical signal will be deleteri-
ously affected by noise contributions occurring during the
transfer of the signal from the MEA to the external filter-
ing and amplifying electronics. These limitations highlight
to the need for an electronic chip with both (i) high den-
sity arrays of sensing electrodes, and (ii) on-chip electronics
for signal processing. The use of CMOS (complementary
metal oxide semiconductor) technology fulfills these tech-
nical requirements (Bai and Wise, 2001; DeBusschere and
Kovacs, 2001; Eversmann et al., 2004).
Microfluidic systems have become very popular for many
bioassays. Two attractive features of microfluidics are espe-
cially useful for cellular assays: (i) the possibility to automate
nutrient delivery, (Tourovskaia et al., 2005; Hung et al., 2004)
and (ii) the capability of directing minute quantities of liquid
to the cells with high precision (Kaji et al., 2003; Takayama
et al., 2003; Matsubara et al., 2004). These microfluidic de-
vices need millimeter-scale fluidic connections and/or reser-
voirs of reagents to ensure the operation of the chip. As a
result, microfluidic chips typically have micrometer-sized
channels and chambers, but generally cover areas of several
square centimeters to allow sufficient space for the connec-
tions to the outside world.
The combination of CMOS technology and microfluidics
will result in a powerful tool, however their relative sizes
are mismatched: CMOS chips are cost efficient only if their
area is kept to minimum (several square millimeters), while
microfluidic systems require areas much larger than that of
CMOS. For microfluidic devices that carry out complex tasks
(i.e., localized drug delivery), the area requirements increase
further because of the large number of necessary fluidic con-
nections to perform these complex tasks. Quake et al. have,
for example, integrated several thousand nL-scale-reactors
on a single microfluidic chip that had a size between 20 and
30 cm2 where each reactor measured several mm2. This is still
many orders of magnitude larger in size than CMOS chips
where μm-sized functionalities can be integrated (Unger
et al., 2000; Liu et al., 2003).
In this contribution, we present a microfluidic device that
can accommodate a diced CMOS MEA. The flow cell covers
an area large enough for simple fluidic connections to the
outside world, with a cavity at the core of the device for
accomodating a CMOS chip. Using a 3-D channel layout,
we performed simple tasks such as nutrient dispensing, and
more complex tasks such as drug assays. We modeled the
Fig. 2 Schematic representation of the flowcell used for flow simula-
tion. The bottom part of the cavity is closed with a Pyrex wafer (by
anodic bonding), all other parts are identical to that described in the
caption of Fig. 1. (a) Side view and (b) top view
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flows in the microfluidic flow cell with simulation software,
and then experimentally demonstrated the capability of the
device for applications in cell biology by locally staining the
HL-1 cardiac myocyte cell line with DNA dyes.
Results and discussion
For the fabrication of the microfluidic device, we selected
a methodology based on silicon micromachining. The ratio-
nale of this approach is to physically separate the fluid han-
dling from the electronics. Starting with a silicon wafer, we
used one side of the wafer for implementing the microfluidic
components (i.e., channels, fluidic connections to the out-
side world), and the other side of the wafer to connect to the
CMOS chip. The silicon wafer is etched through to enable
communication between both worlds (see the schematic rep-
resentation in Fig. 1 and Fig. 2). Applications in cell biology
often require visual observations of the cells with regular
microscopes. For our device, we used transparent materials
to seal the flow cell above the cavity, so that the surface of
the CMOS chip remains visible at any time. This approach
enables the user to apply the same protocols of optical ob-
servation as are used in conventional bioassays.
We designed the overall shape of the flow cell for manufac-
turability with standard micromachining processes. To avoid
Fig. 3 Localized drug delivery
to cells. (a) Schematic side- and
top-view of the drug delivery. A
nutrient flow of nutrient
(20–100 μ L·min−1) is applied
from the inlet to the outlet, and
the drug is injected downwards
into the flow of nutrient at the
entrance of the cavity. The drug
shows a laminar flow profile that
reaches the cells on the bottom
of the flow cell. (b)
Experimental characterization
of the broadening of the drug
streak, top view; a dye was used
to illustrate drug delivery
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the presence of square angles in the flow cell, we formed the
channels and the cavity with KOH wet etching to obtain the
characteristic angle of 54.7◦ for the side walls (as illustrated
in Fig. 2). The flow cell is composed of two channels, each
100 μm deep, that widen until they reach the width of the cav-
ity, and the cavity itself (525 μm deep trough the wafer, and
6 × 6 mm2 or 10 × 10 mm2, depending on the design used).
For the characterization of the flow cell, we sealed the lower
part of the cavity with a Pyrex substrate, instead of bonding to
the CMOS chip. The resulting geometry of the device is very
similar regardless of the approach chosen (Pyrex or CMOS
bottom). The upper part of the flow cell sealed with a trans-
parent lid made of Pyrex glass and a layer of poly (dimethyl-
siloxane) (PDMS) containing molded microfluidic routing
channels. Holes are drilled in the Pyrex substrate for liquid
transport, with inlet and outlet holes aligned to the respective
end of the channels that were etched in the silicon flowcell.
An additional array of holes is available for the localized
introduction of drug. The holes are located within the path
of the nutrient, shortly before the entrance to the cavity (see
also Fig. 2). The PDMS routing layer contains microchannels
connecting the holes in the Pyrex wafer with corresponding
reservoirs, which are adequately spatially separated to al-
low connection to the outside world. The elastomeric PDMS
has the additional advantage of simplifying the connection of
tubing with the microfluidic chip: we obtained leak-free con-
nections by squeezing hard tubing into the reservoir, which
has a slightly smaller diameter than the tubing.
Based on the geometry illustrated in Fig. 2, we carried
out flow simulations using a model developed earlier (Kraus
et al., 2005), which accounted for the gradually increasing
cross-section of the inlet channel and the abrupt change in
geometry of the cavity (i.e., the 54.7◦ opening angle of the cell
cultivation area). We showed that backward flows, that would
disrupt the laminar flow of nutrient delivery, only occur at
flow velocities far larger than those required. With flow rates
of 10, 100 and 1000 μL·min−1 we calculated corresponding
values of 0.05, 0.3 and 1 for the Reynolds numbers (Re).
Backflows were predicted to appear only for Re larger than
50. Under high flow conditions, the shear forces acting on
cells attached to the surface of the cavity could cause the cells
to detach. We calculated that the stress produced by a flow
rate of 300 μL·min−1 resulted in a stress of 11 mPa acting on
the cells bound to the cavity surface (Kraus et al., 2005). This
value is four orders of magnitude lower than that reported to
lead to cell detachment due to shear flow (Lu et al., 2004).
We designed the flow cell in a way that we could exploit
laminar flows to deliver minute amounts of chemical to a
subset of cells in the cavity, see Fig. 3(a). Using the array of
holes located next to the entrance of the cavity (see Fig. 2),
we injected a drug solution from the top into the main flow of
nutrient. The surface area of the cavity that was exposed to
the drug could be modified by adjusting the ratio of nutrient
to drug flow rates [Fig. 3(b)]: high nutrient flow rates led
to narrow drug streaks of drug. In several experiments the
parameters were determined to achieve defined widths of
drug streaks. However, the top-view observations of the dye
did not confirm that the drug injected from the top part of
the flow cell travels all the way to the bottom to reach the
immobilized cells.
We therefore experimentally demonstrated that the drug
reaches the bottom of the flow cell, and hence the seeded
cells, by performing a DNA staining experiment using the
HL-1 cardiac myocytes cell line. We seeded and grew the
cardiac myocytes in the cavity, and before closing the cav-
ity with the Pyrex/PDMS cover, we fixed and permeated
the cells to allow the DNA stain DAPI (4′,6′-diamidine-2
phylindole dihydrochloride) to permeate the membranes and
reach the nuclei of the cells. We sequentially carried out two
delivery experiments with the nutrient flow set at 100 and
50 μL·min−1, while keeping the drug flow rate constant at
1 μL·min−1. Fluorescence microscopy revealed that the nu-
clei became fluorescent when exposed to DAPI, due to the
formation of the fluorescent DNA-DAPI complex (see Fig-
ure 4). The fluorescence demonstrated that the injected chem-
ical does indeed reach the bottom of the flow cell.
Fig. 4 Experimental validation of drug delivery using cardiomyocytes
stained with the DNA stain DAPI. The cells were grown in the 0.6 ×
0.6 cm2 cell cultivation chamber, and the nutrient flow was from left to
right. The drug was introduced at a flow rate of 1μL·min−1. Nutrient
flow was set at 50 μL·min−1 and at 100 μL·min−1 for drug delivery
experiment done with the upper hole and lower hole, respectively. Flu-
orescence intensities for both experiments cannot be directly compared
owing to photobleaching as a consequence of intermediary observation
with a fluorescence microscope
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Fig. 5 CMOS chip layout: (left) Picture of the 4.4 × 4.4 mm2 CMOS chip, and (right) schematic representation of the system architecture
In our first CMOS design, (Heer, et al., 2004) we used
an array of 4 × 4 electrodes, where each electrode has an
associated unit of circuitry which filters and amplifies the
recorded electrical signal. Additionally, each electrode can
be used to apply electrical stimuli to the cellular culture to
elicit an action potential. On-chip multiplexing capabilities
translate into an array size that can be increased with minimal
design changes. A CMOS chip with 128 electrodes is cur-
rently under development. To reduce the number of connec-
tions between off-chip instrumentation and the CMOS chip,
analog-to-digital and digital-to-analog converters, which en-
able signal multiplexing, are included. The system archi-
tecture also incorporate additional functionalities (reference
electrode, temperature sensor, biasing) as illustrated in Fig. 5.
We demonstrated that the system can record electric spikes
(∼1 mV) from active cultures (see Fig. 6). To merge the ca-
pabilities of microfluidics and CMOS, we investigated sev-
eral techniques for bonding the CMOS chip to the silicon
flow cell. Based on our preliminary tests, we selected flip-
chip bonding, and are currently testing the bonding of the
CMOS to the flow cell. The findings that the ‘drug’ does
indeed reach the HL-1 cells is not expected to significantly
change when the glass substrate is replaced with the CMOS
MEA.
Conclusion
We investigated the route to combining the capabilities of
microfluidics with that of CMOS bioelectronic chips, and
to solve the size mismatch between microfluidic devices
and CMOS chips. The ability to control simultaneously the
chemical and electrical environments of electrogenic cells
is important when studying the influence of chemicals on
cellular network activity. The high density arrays of record-
ing/stimulating electrodes available on CMOS chip allow
the activity of individual cells within a cellular network to
be monitored. This capability will provide neurologists and
researchers in life science with instruments to better under-
stand the functioning of the brain, and other tissues that have
electroactive cells, such as in the heart and the intestine. The
approach presented in this contribution integrates important
features of microfluidics and microelectronics, which have
been individually recognized for their usefulness in cell
biology. Compared to other reports (Takayama et al., 2003),
the major drawback of our approach is the low resolution
for the localized drug delivery, which results from the
geometry required for the integration of the CMOS chip
inside the microfluidic device. The lateral resolution is,
however, suitable for a number of bioassays, though this
Fig. 6 Recording of electrical
signals from cells. (a) The
transfer function of the bandpass
filter, and (b) a typical spike
from embryonic chicken cardiac
tissue. High frequencies were
cut-off at 3 kHz
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approach will most likely not achieve drug delivery to single
cells.
Experimental
Fabrication of the nutrient delivery system
in the flow cell
Flow cells for the cultivation of cells were made in a double-
side polished 100-mm diameter, 525-μm-thick silicon wafer,
using 300 nm LPCVD silicon nitride as etch mask for two
etching steps in 40% KOH at 60 ◦C. The first step consisted
of a 425-μm-deep etch of the silicon to define the area where
the cells are to be cultivated. In the second KOH etching step,
100-μm-deep entrance and exit channels to the cell cultica-
tion area were formed to direct nutrients to the cells. At the
same time, the cultivation area was etched further to obtain
a through-hole in the silicon. Flow profile measurements de-
scribed in the first section were performed with flow cells
with a 10 × 10 mm2 cell cultivation chamber. Experiments
with cardiac myocytes were performed in 6×6 mm2-sized
flow cells. The flow cell was closed at the bottom with a piece
of 1.5-mm-thick Pyrex that has been anodically bonded to
the silicon. The top side of the flow cell was closed by a Pyrex
cover-plate. As the surface of the cell cultivation area may
need to be cleaned on a regular basis, we did not use anodic
bonding to close the flow cell from the top side. Instead, sil-
icone grease (polydimethylsiloxane DMS-T63 from ABCR,
Karlsruhe, Germany) with a kinematic viscosity of 25 m2/s
was used to render the structure watertight. Two 1-mm holes
for the delivery of nutrients to the cells were drilled ultra-
sonically in a 100-mm diameter, 500-μm-thick Pyrex wafer,
which was then diced to the size of the flow cell. The flow of
nutrients to the cells was controlled by a Harvard PHD2000
syringe pump using a 20 ml plastic syringe.
Fabrication of the drug delivery system in the flow cell
Holes were drilled in the glass coverplate to locally perfuse
the cells with drugs, using an Lambda Physics LPX-315 ex-
cimer laser at 248 nm (Lambda Physics, Go¨ttingen, Ger-
many). An energy density of approximately 35000 mJ/cm2
at a repetition rate of 100 Hz was used to drill each opening
using 1080 laser pulses (∼11 s per hole). The entrance po-
sition was continuously purged with helium. The exit hole
diameters, used for injection of the drugs, ranged between
40 and 50 μm, while the inlet openings were about 65 μm
in diameter. Each hole, 6–8 in total for each flow cell, was
connected to a microfluidic channel molded in PDMS (Dow
Corning Sylgard 184, Distrelec, Na¨nikon, Switzerland) using
a master produced in SU-8. Tubing (1/16′′ OD, Ercatech AG,
Bern, Switzerland) connecting to the microfluidic channels
were inserted into holes punched into the PDMS liquid rout-
ing layer using a standard punching tool. The PDMS layer
was bonded to the Pyrex cover plate using an oxygen plasma.
The flow of the drugs was controlled by a Harvard PHD2000
syringe pump using a 3 ml plastic syringe. To switch between
the different drug injection holes, we used an Upchurch six-
way valve.
Drug delivery monitored with light
transmission microscopy
Light transmission measurements were performed to investi-
gate the mass transfer properties of the flow cells with liquids
dyed with brilliant blue (Fluka, Buchs, Switzerland), a dye
that has a diffusion coefficient on the same order of mag-
nitude as the diffusion coefficients of larger pharmaceutical
molecules and small proteins. A CCD color camera (JVC
TK-C1380) on a Leica MZ 12 microscope was used to ob-
tain images from the reservoir. Videos were recorded dur-
ing the experiments and digitized with a frame grabber card
(VideoGala from PixelSmart, Canada). Light was provided
via a glass fibre connected to a Leica CLS 150 light source
containing a halogen bulb.
To test the drug injection system, water was pumped con-
tinuously at flow rates between 20 and 100 μL/min. Two
drug injection holes, one located at 0.5 mm from the flow
cell centre (4th hole from the top) and one at a distance of
1.87 mm of its border (hole closest to the edge of the chamber)
were used to introduce tracer into the nutrient flow. Brilliant
blue solution was injected at 1 μL/min. Five minutes were
allowed to obtain a stable concentration profile before each
measurement.
Drug delivery to the HL-1 cell line
The immortalized HL-1 cardiac myocyte cell line (kindly
provided by Dr. W. Claycomb at the Louisiana State Uni-
versity Health Science Center) was used to test the efficacy
of the drug delivery system. The cells were maintained in
Claycomb Medium (JRH Biosciences, USA) supplemented
with 10% fetal bovine serum (JRH Biosciences, USA),
100 units/mL penicillin (Sigma, USA), 100 μg/mL strep-
tomycin (antibiotic/antimycotic solution, Invitrogen, USA),
0.1 mM norepinephrine (Sigma, USA) and 2.0 mM L-
glutamine (Sigma, USA), which was changed approximately
every 24 h. Standard incubation conditions of 37 ◦C, 5% CO2,
95% air and 95% relative humidity were used. Prior to plating
the cells, the microfluidic device was carefully sterilized with
70% ethanol. The culture cavity was pretreated with 0.02%
gelatin for 30 min. An initial seed density of ∼ 30,000 cells
per culture cavity was used. Since the culture volume was so
small (∼ 30 μL) it was necessary to seal the culture while in
the incubator to prevent evaporation. A head space over the
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culture was fabricated from a thick frame of PDMS (15 ×
15 mm2), which was placed around the glass culture cavity,
and a glass cover slip as the lid. The PDMS did not entirely
cover the inlet and outlet channels, thereby allowing for gas
exchange between the head space over the culture and the
controlled incubator environment.
Immediately preceding the drug delivery experiment, the
cells were fixed using 4% paraformaldehyde in phosphate
buffered saline (PBS), and the membrane was permeabilized
with 0.2% Triton X-100 (AppliChem, Germany). Membrane
permeabilization is necessary to allow the stain to reach the
appropriate cellular structures. In this work, the stain 4′,
6′-diamidine-2 phylindole dihydrochloride (DAPI, Sigma,
USA) was prepared with an end concentration of 1 μg/ml
in PBS. The drug delivery experiment was performed using
DAPI as the ‘drug’ at a flow rate of 1 μL/min and PBS as
the buffer at both 50 and 100 μL/min. Finally, fluorescence
microscopy was used to determine which regions, if any, had
been contacted by the stain long enough to bind to the nu-
clear DNA. This experiment was relatively simple to perform
since the cells were dead, and it was no longer necessary to
work under sterile conditions.
System design of the CMOS chip.
The 4.4 × 4.4 mm2 chip presented in Fig. 5 consists of a 4 ×
4 electrode array with integrated reference electrode. Fabri-
cation was performed using an industrial double-polysilicon,
triple-metal, 0.6 μm CMOS process at X-Fab, Dresden, Ger-
many. The electrodes are 40 × 40 μm2 with a 250 μm pitch.
A unit of repeating circuitry comprising a buffer and switch
for stimulation, a bandpass filter and buffer for readout, is
provided with each electrode (inset, Fig. 5). Additionally,
the system architecture incorporates four analog-to-digital
converters (ADC, one per row of electrodes) and one digital-
to-analog converter (DAC). On-chip multiplexing and A/D-
conversion allow for a reduction in the number of bondpads,
which facilitates the integration of a large array. A digital
control unit scans the array during readout, provides individ-
ual electrode addressability for stimulation, and interfaces
with the outside world. Simultaneous recording and stimu-
lation at each electrode can be performed. For the purpose
of monitoring the chip operation temperature and the culture
temperature, a temperature sensor has been included.
Electrode design
Due to the limited selection of materials available in a com-
mercial CMOS process, the electrode material as received
from the foundry is aluminum, known to be toxic to neuron.
A simple 2-mask post-processing procedure is employed to
cover the Al electrodes with biocompatible platinum. It is
necessary to seal the underlying Al to avoid both poisoning
and undesirable electrochemistry that occurs when the Al
comes into contact with the neuron medium. The electrode
metal consists of 50 nm TiW, an adhesion promoter, and
270 nm of Pt. The metals are sputter-deposited and structured
in a lift-off process. An alternating Si3N4/SiO2 passivation
stack consisting of 1μm of Si3N4, and two times 100 nm
SiO2 and 200 nm Si3N4 (total layer thickness of 1.6 μm) is
deposited using plasma-enhanced chemical vapor deposition
(PECVD). A reactive-ion etch (RIE) is then used to open the
nitride stack defining the size and shape of the electrodes.
Detailed information regarding the design of the electronic
circuitry was published previously (Heer et al., 2004).
Electric spike recording from cells.
First tests were performed with an in situ preparation of car-
diomyocytes from fertilized chicken eggs at embryonic day
10. The hearts were extracted from the embryo, briefly rinsed
with cold Dulbecco’s PBS (Sigma D-8531, Ca2+- and Mg2+
-free) and directly transferred onto the electrodes of the chip.
DC-offsets at the electrodes were measured to be up to
1V, which could cause saturation in the first amplification
stage. Since the time-constant of the electrochemistry at the
electrode–electrolyte interface is on the order of seconds, we
used the on-chip stimulation circuitry to set the electrode to
a working point.
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